Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04351269 · ClinicalTrials.gov registry record
Retrospective Experience Of CIED Implantation
A clinical trial of Heart Failure and Coronary Artery Disease, sponsored by Elutia.
- Completed
- Registry status
- 597
- Enrollment target
- 1
- Study location
NCT04351269: Completed study of Heart Failure and Coronary Artery Disease, sponsored by Elutia.
NCT04351269 is a study of Heart Failure and Coronary Artery Disease that has completed, run by Elutia. The registered enrollment target is 597 participants, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04351269, a study of Heart Failure and Coronary Artery Disease, has completed, sponsored by Elutia.
- COMPLETED
- Registry status
- 597 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to retrospectively gather information on patients who underwent a CIED procedure with either a CanGaroo Envelope, TYRX Envelope, or no envelope.
Conditions Studied
Interventions
- DEVICE CanGaroo Envelope
- DEVICE TYRX Envelope
Study Locations (1)
Georgia
- Piedmont Athens Electrophysiology - Athens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 597 participants |
| Start Date | 2020-04-22 |
| Est. Completion | 2021-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04351269
The ClinicalTrials.gov registry entry for NCT04351269 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 597 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (71% lower). The listed sponsor is Elutia, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which CanGaroo Envelope is the first listed.
NCT04351269 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT04351269 about?
NCT04351269 is a clinical study titled "Retrospective Experience Of CIED Implantation". The objective of this study is to retrospectively gather information on patients who underwent a CIED procedure with either a CanGaroo Envelope, TYRX Envelope, or no envelope.
What is the current status of trial NCT04351269?
This trial is currently completed. The enrollment target is 597 participants. The study started on 2020-04-22. Estimated completion is 2021-06-30.
What conditions does trial NCT04351269 study?
This clinical trial studies the following conditions: Heart Failure, Coronary Artery Disease, Cardiac Disease.
What interventions are being tested in trial NCT04351269?
The interventions under investigation include: CanGaroo Envelope (DEVICE), TYRX Envelope (DEVICE).
Who is sponsoring clinical trial NCT04351269?
This trial is sponsored by Elutia, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04351269 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.